ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
11.18
-0.14 (-1.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
ARS Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,087 | 526 | 800 | - | - |
| Market Cap Growth | 289.11% | -34.23% | - | - | - |
| Enterprise Value | 882 | 284 | 839 | - | - |
| Last Close Price | 11.18 | 5.48 | 8.53 | - | - |
| PS Ratio | 547.37 | 17535.50 | 607.80 | - | - |
| PB Ratio | 5.40 | 2.28 | 2.93 | - | - |
| P/TBV Ratio | 7.27 | 2.28 | 2.93 | - | - |
| EV/Sales Ratio | 343.39 | 9483.00 | 637.20 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.20 | 1.40 |
| Debt / FCF Ratio | - | - | - | - | 1.10 |
| Asset Turnover | 0.01 | 0.00 | 0.01 | 0.13 | - |
| Quick Ratio | 12.40 | 95.84 | 50.59 | 7.34 | 3.03 |
| Current Ratio | 12.56 | 96.92 | 51.01 | 7.42 | 3.21 |
| Return on Equity (ROE) | -22.41% | -21.59% | -21.84% | -77.93% | - |
| Return on Assets (ROA) | -16.22% | -16.40% | -12.56% | -27.68% | - |
| Return on Capital (ROIC) | -17.24% | -16.73% | -13.17% | -34.25% | - |
| Earnings Yield | -4.52% | -10.33% | -4.34% | - | - |
| FCF Yield | -4.24% | -11.30% | -5.04% | - | - |
| Buyback Yield / Dilution | -9.54% | -138.30% | -38.39% | -42.81% | - |
| Total Shareholder Return | -9.54% | -138.30% | -38.39% | -42.81% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.